Q&A with Dr. Carole Mitnick, PIH’s co-principal investigator of endTB project Tuberculosis is the most deadly infectious disease, killing more than 1.4 million people globally, most of them in resource-poor countries. Some forms of the disease are resistant to treatment and therefore can’t be cured using standard drugs. These multidrug Read more…
PIH Kazakhstan Country Director Dr. Yerkebulan Algozhin is among staff who have recovered from COVID-19 this year, and said facing a pandemic while continuing tuberculosis care has brought his team closer together – as they now prepare for a second wave of the novel virus. When Dr. Yerkebulan Algozhin heard the Read more…
Despite Kazakhstan’s nationwide lockdown that began in March to contain COVID-19, Partners In Health clinicians have continued to examine and provide treatment—in person and online—for tuberculosis patients enrolled in a groundbreaking clinical trial. Clinicians have had to communicate regularly with police to cross checkpoints and have used their own vehicles Read more…
For more than two decades, Partners In Health has treated and prevented tuberculosis (TB) and its severe, drug-resistant variants in some of the poorest and most vulnerable communities in the world. Our community-based approach to care has resulted in some of the highest cure rates and lowest treatment default rates ever recorded. Read more…
Dr. KJ Seung, who has been fighting tuberculosis with Partners In Health since 2001, urged the World Health Organization and national governments to quickly implement new treatment plans for the deadly infectious disease, in an op-ed published Wednesday in The Lancet Global Health and co-authored by Dr. Cathy Hewison of Read more…
Karim Llaro is a nurse who has worked with Socios En Salud, as Partners In Health is known in Peru, for more than 20 years. She began in the late 1990s as a field nurse, administering tuberculosis treatments to patients in their homes. She then became the TB program coordinator Read more…
In January 2018, Bobby Togar arrived at Liberia’s national tuberculosis annex in the capital of Monrovia for the second time in his life. The 42-year-old thought he was going there to die. He couldn’t eat, and could barely draw the breath to talk. With a body mass index of 10—half Read more…
The imminent launch of two vans equipped with state-of-the-art technology to test for tuberculosis (TB) and multidrug-resistant tuberculosis (MDR-TB) marks a major milestone for PIH’s and Peru’s fight against TB, the leading infectious killer of adults in the world. Within coming weeks, these trucks will enable PIH to carry out Read more…
Dr. Luma at the TB Annex in 2016. (Photo by Rebecca E. Rollins / Partners In Health) Dr. Maxo Luma is a Haitian doctor who was working with Partners In Health in Haiti before coming to Canada in 2007 to continue his education. Dr. Luma is currently the TB Program Read more…
Left to right, patients Monitha Johnson, Monimon Gaye, and Samuel Morris sit outside the Tuberculosis Annex in Monrovia, Liberia, in November 2016, during their treatment for multidrug-resistant tuberculosis. Usually poor. Generally living in the slums or countryside. Busy just trying to stay alive. People who suffer tuberculosis struggle to be seen, Read more…